GB1080979A - New thiepin and wxepin derivatives - Google Patents
New thiepin and wxepin derivativesInfo
- Publication number
- GB1080979A GB1080979A GB46426/65A GB4642665A GB1080979A GB 1080979 A GB1080979 A GB 1080979A GB 46426/65 A GB46426/65 A GB 46426/65A GB 4642665 A GB4642665 A GB 4642665A GB 1080979 A GB1080979 A GB 1080979A
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- compounds
- group
- atom
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D337/14—[b,f]-condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Compounds of the Formula I wherein each of X and Y represent hydrogen, chlorine or bromine atoms or C1- 3 alkyoxy radicals, Z represents a sulphur or oxygen atom, R1 represents a hydrogen atom or a methyl radical, R2 represents a hydrogen atom or a C1- 4 alkyl radical and R3 represents a hydrogen atom or a C1- 4 alkyl radical or R2 and R3 together with the adjacent nitrogen and, optionally, with the inclusion of oxygen having two separate bonds, an imino, C1- 5 alkylimino, C1- 5 hydroxyalkylimino group or an alkanoyloxy alkylimino group of up to 8 carbon atoms as ring member, represent a saturated heterocyclic radical of 5 to 7 ring members, are prepared by reacting compounds of the Formula II with at least double the molar amount of compounds of the formula HNR2R3 or at least double the molar amount of metal compounds of N-acyl derivatives of C1-4 alkylamines, if necessary hydrolysing the reaction products to split off any acyl radicals which may be bound to the nitrogen atom in the side chain, if desired treating a resulting compound of the Formula I containing an imino group as ring member with a C1- 5 alkylene oxide, a reactive mono-ester of a C1- 5 alkane diol or a reactive-ester of an alkanoyloxyalkanol of up to 8 carbon atoms, if desired acylating a compound of the Formula I having a C1- 5 hydroxyalkylimino group as ring member to form a compound having an alkanoyloxyalkylimino group of up to 8 carbon atoms, and, if desired, converting any resulting free base into an acid addition salt thereof with an inorganic or organic acid. <FORM:1080979/C2/1> <FORM:1080979/C2/2> <FORM:1080979/C2/3> <FORM:1080979/C2/4> and <FORM:1080979/C2/5> Thiepins and oxepins of the Formula II may be prepared by reacting the appropriate dibenzo[b,f]thiepin(or oxepin)-10(11H)ione with a metal-methyl or ethyl derivative to give a hydroxy compound of the Formula V, splitting of water and reacting the resulting alkylidene compound of the Formula VI with bromine. Compounds of the Formula VII are formed as by-products in the preparation of compounds of the Formula VI.ALSO:Therapeutic-compositions with adrenolytic and central depressive properties, for oral or parenteral application comprise compounds of the formula (I) <FORM:1080979/A5-A6/1> wherein each of X and Y represents a hydrogen, chlorine or bromine atom or a C1-3 alkyl radical, Z represents a sulphur or oxygen atom, R1 represents a hydrogen atom or methyl radical, each of R2 and R3 represents a hydrogen atom or a C1-4 alkyl radical or R2 and R3, together with the adjacent nitrogen atom and, optionally, with the inclusion of oxygen having two separate bonds, an imino, C1-5 alkylamino or C1-5 hydroxyalkylimino group or an alkenoyloxy alkylimino group of up to 8 carbon atoms, represent a saturated heterocyclic radical of 5-7 ring members, or their salts with organic or inorganic acids, together with a carrier and optionally with other antidepressives.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1421164A CH440318A (en) | 1964-11-03 | 1964-11-03 | Process for the preparation of new thiepin and oxepine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1080979A true GB1080979A (en) | 1967-08-31 |
Family
ID=4398870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB46426/65A Expired GB1080979A (en) | 1964-11-03 | 1965-11-02 | New thiepin and wxepin derivatives |
Country Status (13)
Country | Link |
---|---|
AT (1) | AT254879B (en) |
BE (1) | BE671752A (en) |
BR (1) | BR6574511D0 (en) |
CH (1) | CH440318A (en) |
DE (1) | DE1300954B (en) |
DK (1) | DK109565C (en) |
ES (1) | ES319156A1 (en) |
FI (1) | FI43319C (en) |
FR (2) | FR1453003A (en) |
GB (1) | GB1080979A (en) |
IL (1) | IL24558A (en) |
NL (1) | NL6514187A (en) |
SE (1) | SE315598B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780501A (en) * | 1995-02-08 | 1998-07-14 | Novartis Corporation | Treatment method using anti-neurodegeneratively active 10-aminoaliphatyl-dibenz b,f!oxepines |
WO2003057204A2 (en) * | 2002-01-08 | 2003-07-17 | Nordic Bioscience A/S | Modulation of iamt (pimt or pcmt) in immune system |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2020207A1 (en) * | 1968-10-09 | 1970-07-10 | Leo Ab | CNS-active tri:cyclic amino:ketone(s) |
CH507232A (en) * | 1968-11-27 | 1971-05-15 | Ciba Geigy Ag | Thiepin and oxepin derivs |
-
1964
- 1964-11-03 CH CH1421164A patent/CH440318A/en unknown
-
1965
- 1965-10-26 FI FI652550A patent/FI43319C/en active
- 1965-11-02 SE SE14127/65A patent/SE315598B/xx unknown
- 1965-11-02 DE DEG45082A patent/DE1300954B/en active Pending
- 1965-11-02 AT AT986265A patent/AT254879B/en active
- 1965-11-02 GB GB46426/65A patent/GB1080979A/en not_active Expired
- 1965-11-02 NL NL6514187A patent/NL6514187A/xx unknown
- 1965-11-02 DK DK561565AA patent/DK109565C/en active
- 1965-11-02 ES ES0319156A patent/ES319156A1/en not_active Expired
- 1965-11-03 IL IL24558A patent/IL24558A/en unknown
- 1965-11-03 FR FR37079A patent/FR1453003A/en not_active Expired
- 1965-11-03 BE BE671752D patent/BE671752A/xx unknown
- 1965-11-03 BR BR174511/65A patent/BR6574511D0/en unknown
-
1966
- 1966-02-02 FR FR48142A patent/FR5388M/fr not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780501A (en) * | 1995-02-08 | 1998-07-14 | Novartis Corporation | Treatment method using anti-neurodegeneratively active 10-aminoaliphatyl-dibenz b,f!oxepines |
US5780500A (en) * | 1995-02-08 | 1998-07-14 | Novartis Corporation | Anti-neurodegeneratively active 10-aminoaliphatyl-dibenzi b,f! oxepines |
WO2003057204A2 (en) * | 2002-01-08 | 2003-07-17 | Nordic Bioscience A/S | Modulation of iamt (pimt or pcmt) in immune system |
WO2003057204A3 (en) * | 2002-01-08 | 2004-02-05 | Nordic Bioscience As | Modulation of iamt (pimt or pcmt) in immune system |
Also Published As
Publication number | Publication date |
---|---|
DK109565C (en) | 1968-05-13 |
ES319156A1 (en) | 1966-07-01 |
SE315598B (en) | 1969-10-06 |
FR5388M (en) | 1967-09-18 |
BR6574511D0 (en) | 1973-08-16 |
IL24558A (en) | 1969-09-25 |
DE1300954B (en) | 1969-08-14 |
AT254879B (en) | 1967-06-12 |
FI43319C (en) | 1971-03-10 |
FI43319B (en) | 1970-11-30 |
CH440318A (en) | 1967-07-31 |
NL6514187A (en) | 1966-05-04 |
FR1453003A (en) | 1966-04-15 |
BE671752A (en) | 1966-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3877386D1 (en) | ANTI-CANCER LINKS. | |
GR3021971T3 (en) | Imidazonaphthyridine derivatives | |
GB1080979A (en) | New thiepin and wxepin derivatives | |
ATE96446T1 (en) | ESRAMUSTINE ESTER. | |
MX170732B (en) | COMPOSITION OF SUCCINIMIDE DERIVATIVES AND THEIR USE | |
ATE169289T1 (en) | IMIDO-PERCARBONIC ACIDS | |
NO940265L (en) | Process for the preparation of sulfur-containing carboxylic acid amides | |
GB9119281D0 (en) | Compound use and preparation | |
GB1471751A (en) | Piperidine derivatives | |
ES2186605T3 (en) | PROCEDURE FOR THE SYNTHESIS OF 5-ALYLBENZODIOXOLS. | |
EP0178580A3 (en) | Intermediates for the synthesis of carboxylic acids | |
GB1060140A (en) | New thiepine and oxepine derivatives | |
IL78625A0 (en) | Furanone derivatives and their preparation | |
GB1046260A (en) | Azepine derivatives and process for their production | |
GB1003476A (en) | Indolo quinolizines | |
JPS6434981A (en) | Production of dithiolane derivative |